Scotiabank Weighs in on Albemarle’s Q3 Earnings (NYSE:ALB)

Albemarle Corporation (NYSE:ALB) – Stock analysts at Scotiabank issued their Q3 2026 EPS estimates for shares of Albemarle in a report issued on Monday, August 10th. Scotiabank analyst B. Isaacson expects that the specialty chemicals company will post earnings of $2.67 per share for the quarter. Scotiabank currently has a “Sector Outperform” rating and a $190.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is $12.73 per share.

Albemarle (NYSE:ALB) last released its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 EPS for the quarter, beating the consensus estimate of $3.20 by $0.55. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.61 billion. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The firm’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.11 EPS.

Other equities research analysts have also issued research reports about the company. UBS Group lowered their target price on Albemarle from $205.00 to $175.00 and set a “buy” rating for the company in a research note on Friday. Zacks Research lowered Albemarle from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Oppenheimer lifted their price target on Albemarle from $216.00 to $222.00 and gave the stock an “outperform” rating in a research note on Monday, April 13th. Robert W. Baird dropped their price objective on Albemarle from $236.00 to $224.00 and set a “neutral” rating for the company in a research note on Thursday, June 18th. Finally, Citigroup cut their target price on shares of Albemarle from $225.00 to $175.00 and set a “buy” rating on the stock in a report on Friday. Fifteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Albemarle currently has an average rating of “Moderate Buy” and an average price target of $190.26.

Albemarle Stock Up 0.1%

Shares of NYSE:ALB opened at $131.29 on Tuesday. The stock’s 50-day moving average price is $136.81 and its 200-day moving average price is $163.79. Albemarle has a 12-month low of $71.25 and a 12-month high of $221.00. The stock has a market capitalization of $15.49 billion, a P/E ratio of 486.28 and a beta of 1.33. The company has a current ratio of 2.09, a quick ratio of 1.35 and a debt-to-equity ratio of 0.22.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Addison Advisors LLC purchased a new position in Albemarle during the second quarter valued at $28,000. BOKF NA increased its holdings in shares of Albemarle by 5,771.4% during the third quarter. BOKF NA now owns 411 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 404 shares in the last quarter. Elyxium Wealth LLC bought a new position in shares of Albemarle during the fourth quarter valued at $34,000. EverSource Wealth Advisors LLC raised its position in shares of Albemarle by 536.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company’s stock worth $36,000 after purchasing an additional 483 shares during the last quarter. Finally, Torren Management LLC purchased a new position in shares of Albemarle in the 4th quarter worth about $38,000. Institutional investors own 92.87% of the company’s stock.

Insider Buying and Selling at Albemarle

In other news, CEO J Kent Masters sold 16,393 shares of Albemarle stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $183.72, for a total transaction of $3,011,721.96. Following the completion of the transaction, the chief executive officer directly owned 87,519 shares in the company, valued at approximately $16,078,990.68. This trade represents a 15.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.42% of the company’s stock.

Albemarle Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Friday, September 11th will be paid a dividend of $0.41 per share. This is a positive change from Albemarle’s previous quarterly dividend of $0.41. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, September 11th. Albemarle’s payout ratio is 600.00%.

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.